中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
25期
107-109
,共3页
艾迪注射液%中晚期肺癌%生活质量%应用价值
艾迪註射液%中晚期肺癌%生活質量%應用價值
애적주사액%중만기폐암%생활질량%응용개치
Aidi injection%Middle-late stage lung cancer%Quality of life%Application value
目的：探讨艾迪注射液在中晚期肺癌患者中的应用价值及对生活质量的影响。方法选取2011年3月~2014年3月本院收治的中晚期肺癌患者71例，随机分为两组，其中观察组36例，应用艾迪注射液联合DP方案(顺铂、多西他赛)，对照组35例，仅选用DP方案进行化疗，观察并比较两组患者的临床疗效、不良反应发生情况与治疗后生活质量的变化。结果观察组完全缓解2例(5.6%)，部分缓解12例(33.3%)，稳定17例(47.2%)，进展5例(13.9%)；对照组完全缓解2例(5.7%)，部分缓解13例(37.1%)，稳定14例(40.0%)，进展6例(17.1%)，两组差异无统计学意义(P>0.05)。观察组患者治疗后的生活质量改善情况明显优于对照组，两组差异有统计学意义(P<0.05)。结论艾迪注射液在中晚期肺癌患者中的应用价值较高，毒副作用小，能够较大幅度提高患者的生活质量，值得在临床推广。
目的：探討艾迪註射液在中晚期肺癌患者中的應用價值及對生活質量的影響。方法選取2011年3月~2014年3月本院收治的中晚期肺癌患者71例，隨機分為兩組，其中觀察組36例，應用艾迪註射液聯閤DP方案(順鉑、多西他賽)，對照組35例，僅選用DP方案進行化療，觀察併比較兩組患者的臨床療效、不良反應髮生情況與治療後生活質量的變化。結果觀察組完全緩解2例(5.6%)，部分緩解12例(33.3%)，穩定17例(47.2%)，進展5例(13.9%)；對照組完全緩解2例(5.7%)，部分緩解13例(37.1%)，穩定14例(40.0%)，進展6例(17.1%)，兩組差異無統計學意義(P>0.05)。觀察組患者治療後的生活質量改善情況明顯優于對照組，兩組差異有統計學意義(P<0.05)。結論艾迪註射液在中晚期肺癌患者中的應用價值較高，毒副作用小，能夠較大幅度提高患者的生活質量，值得在臨床推廣。
목적：탐토애적주사액재중만기폐암환자중적응용개치급대생활질량적영향。방법선취2011년3월~2014년3월본원수치적중만기폐암환자71례，수궤분위량조，기중관찰조36례，응용애적주사액연합DP방안(순박、다서타새)，대조조35례，부선용DP방안진행화료，관찰병비교량조환자적림상료효、불량반응발생정황여치료후생활질량적변화。결과관찰조완전완해2례(5.6%)，부분완해12례(33.3%)，은정17례(47.2%)，진전5례(13.9%)；대조조완전완해2례(5.7%)，부분완해13례(37.1%)，은정14례(40.0%)，진전6례(17.1%)，량조차이무통계학의의(P>0.05)。관찰조환자치료후적생활질량개선정황명현우우대조조，량조차이유통계학의의(P<0.05)。결론애적주사액재중만기폐암환자중적응용개치교고，독부작용소，능구교대폭도제고환자적생활질량，치득재림상추엄。
Objective To explore the application value and influence on quality of life of Aidi injection in middle-late stage lung cancer patients. Methods 71 patients with middle-late stage lung cancer treated in our hospital from March 2011 to March 2014 were selected and randomly divided into two groups,observation group in 36 cases were given Aidi injection combined with DP regimen (cisplatin,docetaxel) treatment,35 patients control group in 35 cases were only used DP regimen chemotherapy.The clinical efficacy,incidence of adverse reactions,changes in the quality of life after treat-ment of the patients in the two groups were observed and compared. Results Complete remission in 2 cases (5.6%),par-tial remission in 12 cases (33.3%),stable in 17 cases (47.2%) and progress in 5 cases (13.9%) in the observation group, complete remission in 2 cases (5.7%),partial remission in 13 cases (37.1%),stable in 14 cases (40.0%) and progress in 6 cases (17.1%) in the control group,the differences between the two groups had no statistical significance (P>0.05).The quality of life improved after treatment in observation group patients was better than that of control group,the differ-ences between the two groups had statistical significance (P<0.05). Conclusion The value of Aidi injection in advanced lung cancer is high,side effects of small,it can greatly improve the life quality of patients,is worth popularizing in clini-cal.
